United Therapeutics (UTHR) Selling, General & Administrative (2009 - 2026)
Powered by 
Analysis
United Therapeutics (UTHR) Selling, General & Administrative (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.50 Bn | 622.74 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 440.29 Bn | 433.72 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 364.93 Bn | 357.79 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 266.65 Bn | 258.96 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Pfizer | 158.92 Bn | 147.22 Bn | 10.94 Bn | 3.41 Bn |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | -2.87 Bn |
| 7 | Revolution Medicines | 44.32 Bn | 44.32 Bn | - | 110.21 Mn |
| 8 | Incyte | 25.32 Bn | 20.78 Bn | 1.57 Bn | 351.74 Mn |
| 9 | United Therapeutics | 21.42 Bn | 18.75 Bn | 683.80 Mn | 206.70 Mn |
| 10 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 439.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 206.70 Mn |
| Mar 31, 2026 | 184.10 Mn |
| Dec 31, 2025 | 190.60 Mn |
| Sep 30, 2025 | 182.60 Mn |
| Jun 30, 2025 | 212.50 Mn |
| Mar 31, 2025 | 170.10 Mn |
| Dec 31, 2024 | 168.50 Mn |
| Sep 30, 2024 | 219.20 Mn |
| Jun 30, 2024 | 177.60 Mn |
| Mar 31, 2024 | 144.40 Mn |
| Dec 31, 2023 | 132.20 Mn |
| Sep 30, 2023 | 127.60 Mn |
| Jun 30, 2023 | 130.00 Mn |
| Mar 31, 2023 | 87.30 Mn |
| Dec 31, 2022 | 163.20 Mn |
| Sep 30, 2022 | 98.40 Mn |
| Jun 30, 2022 | 141.50 Mn |
| Mar 31, 2022 | 79.00 Mn |
| Dec 31, 2021 | 127.90 Mn |
| Sep 30, 2021 | 109.10 Mn |